Fig. 1: Comparison of clinical indicators in different groups.
From: VCL/ICAM-1 pathway is associated with lung inflammatory damage in SARS-CoV-2 Omicron infection
a Blood Routine: Comparison of white blood cell count (WBC), neutrophil count (NEU), lymphocyte count (LYM), monocyte count (MONO), C-reactive protein (CRP), and their respective percentages across healthy controls, Omi-Asymptomatic, Omi-Symptomatic, and ancestral groups. b Biochemistry: Plasma levels of various biochemical markers including Blood urea nitrogen (BUN), Glucose (GLU), Creatinine (Cr) and Calcium (Ca). c Thromboembolism and Myocardial Injury: Coagulation parameters including activated partial thromboplastin time (APTT), D-dimer (D-D), fibrinogen (FIB), prothrombin time (PT), and markers of myocardial injury such as myoglobin (MYO), lactate dehydrogenase (LDH), creatine kinase (CK), and aspartate aminotransferase (AST). d Blood Gas Analysis: Parameters indicative of respiratory and metabolic status including pH, hemoglobin (Hb), methemoglobin (MetHb), hematocrit (Hct), standard base excess (SBE), and standard bicarbonate (SBC). e Lymphocyte Subpopulations: Levels of various lymphocyte subpopulations including CD3 + CD8 + , CD3 + CD19 + , CD3 + CD15 + , CD4 + CD8 + , CD3 + CD4 + , CD3 + CD45 + , CD3 + CD56 + CD16 + , and CD3 + CD16 + CD56+ across the different patient groups. Data are presented as mean values ± SEM. n (healthy control) = 20. n (Omi-Asymptomatic) = 20. n (Omi-Symptomatic) = 20. n (ancestral) = 20. Statistical significance was determined using one-way ANOVA followed by Tukey’s post hoc test for multiple comparisons. ***P < 0.001; **P < 0.01; *P < 0.05.
